Statements of Shareholders' Deficiency - USD ($)	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balances	$ (931,279)	$ (835,587)
Net loss	(103,850)	(95,692)
Ending balances	$ (1,035,129)	$ (931,279)
Common Stock
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Shares, beginning balance (in shares)	1,899,575	1,899,575
Beginning balances	$ 1,900	$ 1,900
Shares, ending balance (in shares)	1,899,575	1,899,575
Ending balances	$ 1,900	$ 1,900
Additional Paid-in Capital
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balances	8,418,684	8,418,684
Ending balances	8,418,684	8,418,684
Accumulated Deficit
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balances	(9,351,863)	(9,256,171)
Net loss	(103,850)	(95,692)
Ending balances	$ (9,455,713)	$ (9,351,863)